A randomized trial of dietary sodium restriction in CKD

Journal of the American Society of Nephrology

Volumn 24, Issue 12, 2013, Pages 2096-2103

  McMahon, Emma J ^a,b   Bauer, Judith D ^b   Hawley, Carmel M ^a,b   Isbel, Nicole M ^a,b   Stowasser, Michael ^a,b   Johnson, David W ^a,b   Campbell, Katrina L ^a,b  

^a PRINCESS ALEXANDRA HOSPITAL   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALDOSTERONE; PLACEBO; PROTEIN; RENIN; SALT INTAKE;

AGED; ALBUMIN EXCRETION; ALBUMINURIA; ARTERIAL STIFFNESS; ARTICLE; AUGMENTATION INDEX; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; BODY COMPOSITION; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE COURSE; DOUBLE BLIND PROCEDURE; EXCRETION; EXTRACELLULAR SPACE; FEMALE; HIGH SODIUM INTAKE; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN EXCRETION; PROTEIN URINE LEVEL; PROTEINURIA; PULSE WAVE; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SODIUM INTAKE; SODIUM RESTRICTION; BLOOD PRESSURE; DIET THERAPY; HYPERTENSION, RENAL; MIDDLE AGED; NEW ZEALAND; PATIENT COMPLIANCE; PROCEDURES; RENAL INSUFFICIENCY, CHRONIC; RISK FACTOR; RISK REDUCTION; SALT INTAKE; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME;

AGED; BLOOD PRESSURE; CROSS-OVER STUDIES; DIET, SODIUM-RESTRICTED; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPERTENSION, RENAL; MALE; MIDDLE AGED; NEW ZEALAND; PATIENT COMPLIANCE; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; RISK REDUCTION BEHAVIOR; SODIUM CHLORIDE, DIETARY; TREATMENT OUTCOME;

EID: 84889028358     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2013030285     Document Type: Article

References (42)

1. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351: 1296-1305, 2004
2. Agrawal V, Marinescu V, Agarwal M, McCullough PA: Cardiovascular implications of proteinuria: An indicator of chronic kidney disease. Nat Rev Cardiol 6: 301-311, 2009
3. Vanholder R, Massy Z, Argiles A, Spasovski G, Verbeke F, Lameire N; European Uremic Toxin Work Group: Chronic kidney disease as cause of cardiovascular morbidity and mortality. Nephrol Dial Transplant 20: 1048-1056, 2005
4. Basile JN: Recognizing the link between CKD and CVD in the primary care setting: Accurate and early diagnosis for timely and appropriate intervention. South Med J 100: 499-505, 2007
5. Thijssen S, Kitzler TM, Levin NW: Salt: Its role in chronic kidney disease. J Ren Nutr 18: 18-26, 2008
6. Wright JA, Cavanaugh KL: Dietary sodium in chronic kidney disease: A comprehensive approach. Semin Dial 23: 415-421, 2010
7. Suckling RJ, He FJ, Macgregor GA: Altered dietary salt intake for preventing and treating diabetic kidney disease. Cochrane Database Syst Rev 12: CD006763, 2010
8. Graudal NA, Hubeck-Graudal T, Jürgens G: Effects of low-sodium diet vs. high-sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol, and triglyceride (Cochrane Review). Am J Hypertens 25: 1-15, 2012
9. Essig M, Escoubet B, de Zuttere D, Blanchet F, Arnoult F, Dupuis E, Michel C, Mignon F, Mentre F, Clerici C, Vrtovsnik F: Cardiovascular remodelling and extracellular fluid excess in early stages of chronic kidney disease. Nephrol Dial Transplant 23: 239-248, 2008
10. Slagman MC,Waanders F, Hemmelder MH,Woittiez AJ, JanssenWM, Lambers Heerspink HJ, Navis G, Laverman GD; Holland Nephrology Study Group: Moderate dietary sodium restriction added to angiotensin converting enzyme inhibition compared with dual blockade in lowering proteinuria and blood pressure: Randomised controlled trial. BMJ 343: d4366, 2011
11. Vogt L, Waanders F, Boomsma F, de Zeeuw D, Navis G: Effects of dietary sodiumand hydrochlorothiazide on the antiproteinuric efficacy of losartan. J Am Soc Nephrol 19: 999-1007, 2008
12. Schmieder RE, Mann JF, Schumacher H, Gao P, Mancia G, Weber MA, McQueen M, Koon T, Yusuf S; ONTARGET Investigators: Changes in albuminuria predict mortality and morbidity in patients with vascular disease. J Am Soc Nephrol 22: 1353-1364, 2011
13. Al-Solaiman Y, Jesri A, Zhao Y, Morrow JD, Egan BM: Low-sodium DASH reduces oxidative stress and improves vascular function in saltsensitive humans. J Hum Hypertens 23: 826-835, 2009
14. Rugale C, Delbosc S, Cristol JP, Mimran A, Jover B: Sodium restriction prevents cardiac hypertrophy and oxidative stress in angiotensin II hypertension. Am J Physiol Heart Circ Physiol 284: H1744-H1750, 2003
15. Todd AS, Macginley RJ, Schollum JB, Johnson RJ, Williams SM, SutherlandWH,Mann JI,Walker RJ: Dietary salt loading impairs arterial vascular reactivity. Am J Clin Nutr 91: 557-564, 2010
16. Cianciaruso B, Bellizzi V, Minutolo R, Colucci G, Bisesti V, Russo D, Conte G, De Nicola L: Renal adaptation to dietary sodium restriction in moderate renal failure resulting from chronic glomerular disease. J Am Soc Nephrol 7: 306-313, 1996
17. Bellizzi V, Di Iorio BR, De Nicola L, Minutolo R, Zamboli P, Trucillo P, Catapano F, Cristofano C, Scalfi L, ConteG; ERIKA StudyGroup: Very low protein diet supplemented with ketoanalogs improves blood pressure control in chronic kidney disease. Kidney Int 71: 245-251, 2007
18. Koomans HA, Roos JC, Dorhout Mees EJ, Delawi IM: Sodium balance in renal failure. A comparison of patients with normal subjects under extremes of sodium intake. Hypertension 7: 714-721, 1985
19. Fine A, Fontaine B, Ma M: Commonly prescribed salt intake in continuous ambulatory peritoneal dialysis patients is too restrictive: Results of a double-blind crossover study. J Am Soc Nephrol 8: 1311-1314, 1997
20. Keven K, Yalçin S, Canbakan B, Kutlay S, Sengül S, Erturk S, Erbay B: The impact of daily sodium intake on posttransplant hypertension in kidney allograft recipients. Transplant Proc 38: 1323-1326, 2006
21. Konishi Y,Nishiyama A,Morikawa T, Kitabayashi C, Shibata M, Hamada M, KishidaM,HitomiH, KiyomotoH,Miyashita T,Mori N, UrushiharaM, Kobori H, Imanishi M: Relationship between urinary angiotensinogen and salt sensitivity of blood pressure in patients with IgA nephropathy. Hypertension 58: 205-211, 2011
22. Ruilope LM, Casal MC, Guerrero L, Alcázar JM, Férnandez ML, Lahera V, Rodicio JL: Sodium intake does not influence the effect of verapamil in hypertensive patients with mild renal insufficiency. Drugs 44[Suppl 1]: 94-98, 1992
23. Bie P, Sandgaard NC: Determinants of the natriuresis after acute, slow sodium loading in conscious dogs. Am J Physiol Regul Integr Comp Physiol 278: R1-R10, 2000
24. Heran BS, Wong MM, Heran IK, Wright JM: Blood pressure lowering efficacy of angiotensin converting enzyme (ACE) inhibitors for primary hypertension. Cochrane Database Syst Rev (4): CD003823, 2008
25. LawMR, Morris JK, Wald NJ: Use of blood pressure lowering drugs in the prevention of cardiovascular disease: Meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ 338: b1665, 2009
26. Agarwal R, Andersen MJ: Prognostic importance of ambulatory blood pressure recordings in patients with chronic kidney disease. Kidney Int 69: 1175-1180, 2006
27. O'Brien E, Asmar R, Beilin L, Imai Y,Mallion JM,ManciaG,Mengden T, Myers M, Padfield P, Palatini P, Parati G, Pickering T, Redon J, Staessen J, Stergiou G, Verdecchia P; European Society of Hypertension Working Group on Blood Pressure Monitoring: European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J Hypertens 21: 821-848, 2003
28. Jürgens G, Graudal NA: Effects of low sodium diet versus high sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterols, and triglyceride. Cochrane Database Syst Rev (1): CD004022, 2004
29. Geleijnse JM, Kok FJ, Grobbee DE: Blood pressure response to changes in sodium and potassium intake: A metaregression analysis of randomised trials. J Hum Hypertens 17: 471-480, 2003
30. He FJ, MacGregor GA: Effect of longer-term modest salt reduction on blood pressure. Cochrane Database Syst Rev (3): CD004937, 2004
31. Kimura G, Dohi Y, Fukuda M: Salt sensitivity and circadian rhythm of blood pressure: The keys to connect CKD with cardiovascular events. Hypertens Res 33: 515-520, 2010
32. Koomans HA, Roos JC, Boer P, Geyskes GG, Mees EJ: Salt sensitivity of blood pressure in chronic renal failure. Evidence for renal control of body fluid distribution in man. Hypertension 4: 190-197, 1982
33. Calhoun DA, JonesD, Textor S, Goff DC,Murphy TP, Toto RD,White A, CushmanWC,WhiteW, SicaD, Ferdinand K,Giles TD, Falkner B, Carey RM: Resistant hypertension: Diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension 51: 1403-1419, 2008
34. Pimenta E, Gaddam KK, Oparil S, Aban I, Husain S, Dell'Italia LJ, Calhoun DA: Effects of dietary sodium reduction on blood pressure in subjects with resistant hypertension: results from a randomized trial. Hypertension 54: 475-481, 2009
35. Agarwal R: Ambulatory blood pressure and cardiovascular events in chronic kidney disease. Semin Nephrol 27: 538-543, 2007
36. World Health Organization: Effect of Reduced SodiumIntake on Blood Pressure, Renal Function, Blood Lipids and Other Potential Adverse Effects, Geneva, Switzerland, World Health Organization, 2012
37. Fedorova OV, Agalakova NI, Talan MI, Lakatta EG, Bagrov AY: Brain ouabain stimulates peripheral marinobufagenin via angiotensin II signalling in NaCl-loaded Dahl-S rats. J Hypertens 23: 1515-1523, 2005
38. Fedorova LV, Raju V, El-Okdi N, Shidyak A, Kennedy DJ, Vetteth S, Giovannucci DR, Bagrov AY, Fedorova OV, Shapiro JI, Malhotra D: The cardiotonic steroid hormone marinobufagenin induces renal fibrosis: Implication of epithelial-to-mesenchymal transition. AmJ Physiol Renal Physiol 296: F922-F934, 2009
39. McMahon EJ, Bauer JD, Hawley CM, Isbel NM, Stowasser M, Johnson DW, Hale RE, Campbell KL: The effect of lowering salt intake on ambulatory blood pressure to reduce cardiovascular risk in chronic kidney disease (LowSALT CKD study): Protocol of a randomized trial. BMC Nephrol 13: 137, 2012
40. Konishi Y,Okada N,Okamura M,Morikawa T, Okumura M, Yoshioka K, Imanishi M: Sodium sensitivity of blood pressure appearing before hypertension and related to histological damage in immunoglobulin a nephropathy. Hypertension 38: 81-85, 2001
41. SphymoCor: SphymoCorCMV Research ApplicationsManual, Sydney, Australia, AtCor Medical Pty. Ltd., 2010
42. McMahon EJ, Campbell KL, Mudge DW, Bauer JD: Achieving salt restriction in chronic kidney disease. Int J Nephrol 2012: 720429, 2012